+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain"

Gabapentin - Global Strategic Business Report - Product Thumbnail Image

Gabapentin - Global Strategic Business Report

  • Report
  • September 2025
  • 477 Pages
  • Global
From
Pain Management Drugs - Global Strategic Business Report - Product Thumbnail Image

Pain Management Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Non-opioid Pain Patch - Global Strategic Business Report - Product Thumbnail Image

Non-opioid Pain Patch - Global Strategic Business Report

  • Report
  • September 2025
  • 194 Pages
  • Global
From
Analgesics - Global Strategic Business Report - Product Thumbnail Image

Analgesics - Global Strategic Business Report

  • Report
  • September 2025
  • 578 Pages
  • Global
From
From
Pain Management Devices - Global Strategic Business Report - Product Thumbnail Image

Pain Management Devices - Global Strategic Business Report

  • Report
  • September 2025
  • 118 Pages
  • Global
From
From
Neuropathic Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Neuropathic Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Neuropathic Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Neuropathic Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Peripheral Neuropathic Pain-Pipeline Insight, 2025 - Product Thumbnail Image

Peripheral Neuropathic Pain-Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hyperalgesia - Pipeline Insight, 2025 - Product Thumbnail Image

Hyperalgesia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
From
Gabapentin Market Report and Forecast 2025-2034 - Product Thumbnail Image

Gabapentin Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
From
From
Loading Indicator

Neuropathic pain is a type of chronic pain caused by damage to the nervous system. It is often described as a burning, tingling, or shooting sensation. Analgesics are medications used to reduce or eliminate pain. Neuropathic pain is often treated with a combination of analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and anticonvulsants. Other treatments may include physical therapy, nerve blocks, and electrical stimulation. The neuropathic pain market is a rapidly growing segment of the analgesics market. It is driven by the increasing prevalence of chronic pain conditions, such as diabetes, cancer, and multiple sclerosis. The market is expected to benefit from the development of novel treatments, such as gene therapy and stem cell therapy. Some companies in the neuropathic pain market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more